Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 329.1K | $9.0M | 8.85% | -- | 2026-06-30 |
| Murchinson Ltd. | 304.3K | $8.0M | 8.18% | +8.0K | 2026-06-30 |
| Ikarian Capital, LLC | 256.6K | $7.0M | 6.90% | -- | 2026-06-30 |
| BOOTHBAY FUND MANAGEMENT, LLC | 102.0K | $2.0M | 2.74% | +20.1K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 97.1K | $2.0M | 2.61% | +4.0K | 2026-06-30 |
| J. Goldman & Co LP | 38.1K | $1.0M | 1.02% | -12.3K | 2026-06-30 |
| DIADEMA PARTNERS LP | 24.8K | -- | 0.67% | -- | 2026-06-30 |
| WEXFORD CAPITAL LP | 22.4K | -- | 0.60% | -- | 2026-06-30 |
| Knott David M Jr | 22.1K | -- | 0.59% | +1.0K | 2026-06-30 |
| CITADEL ADVISORS LLC | 15.0K | -- | 0.40% | -- | 2026-06-30 |
